NDC 53808-0205

Asacol

Mesalamine

Asacol is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Mesalamine.

Product ID53808-0205_bac1e923-6161-462a-bfd3-37cfb34a7313
NDC53808-0205
Product TypeHuman Prescription Drug
Proprietary NameAsacol
Generic NameMesalamine
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2009-07-01
Marketing CategoryNDA / NDA
Application NumberNDA019651
Labeler NameState of Florida DOH Central Pharmacy
Substance NameMESALAMINE
Active Ingredient Strength400 mg/1
Pharm ClassesAminosalicylate [EPC],Aminosalicylic Acids [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 53808-0205-1

30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (53808-0205-1)
Marketing Start Date2009-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53808-0205-1 [53808020501]

Asacol TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA019651
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-07-01
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
MESALAMINE400 mg/1

Pharmacological Class

  • Aminosalicylate [EPC]
  • Aminosalicylic Acids [CS]

NDC Crossover Matching brand name "Asacol" or generic name "Mesalamine"

NDCBrand NameGeneric Name
53808-0205AsacolAsacol
53808-0823ASACOLASACOL
55154-2305AsacolAsacol
0023-5901Asacol HDmesalamine
0430-0783ASACOL HDmesalamine
0023-5853Delzicolmesalamine
0179-0142Lialdamesalamine
0093-5907MesalamineMesalamine
0093-9224mesalaminemesalamine
0378-1375Mesalaminemesalamine
0378-9230Mesalaminemesalamine
0472-1915MesalamineMesalamine
0037-0066Rowasamesalamine
0037-0022sfRowasamesalamine

Trademark Results [Asacol]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ASACOL
ASACOL
76560719 3291293 Dead/Cancelled
MEDEVA PHARMA SUISSE AG
2003-11-17
ASACOL
ASACOL
73465464 1372087 Live/Registered
J. B. TILLOTT LIMITED
1984-02-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.